152 related articles for article (PubMed ID: 31209706)
1. The expression and clinical significance of different forms of LILRA3 in systemic lupus erythematosus.
Du Y; Sun F; Zhou M; Wu X; Sun W; Jiang Y; Cheng Q; Chen X; Wu H; Xue J
Clin Rheumatol; 2019 Nov; 38(11):3099-3107. PubMed ID: 31209706
[TBL] [Abstract][Full Text] [Related]
2. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
[TBL] [Abstract][Full Text] [Related]
3. The expression and clinical significance of different forms of Mer receptor tyrosine kinase in systemic lupus erythematosus.
Zhu H; Sun X; Zhu L; Hu F; Shi L; Li Z; Su Y
J Immunol Res; 2014; 2014():431896. PubMed ID: 24741600
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of PD-L1 on CD14⁺ monocyte in the peripheral blood of patients with systemic lupus erythematosus].
Xie CH; Wang YY; Li ZJ; Tang J; Li BQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):429-32. PubMed ID: 22482418
[TBL] [Abstract][Full Text] [Related]
5. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.
Biesen R; Demir C; Barkhudarova F; Grün JR; Steinbrich-Zöllner M; Backhaus M; Häupl T; Rudwaleit M; Riemekasten G; Radbruch A; Hiepe F; Burmester GR; Grützkau A
Arthritis Rheum; 2008 Apr; 58(4):1136-45. PubMed ID: 18383365
[TBL] [Abstract][Full Text] [Related]
6. Reduced expressions of Fas and Bcl-2 proteins in CD14+ monocytes and normal CD14 soluble levels in juvenile systemic lupus erythematosus.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
Lupus; 2013 Aug; 22(9):940-7. PubMed ID: 23846229
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus.
Vordenbäumen S; Fischer-Betz R; Timm D; Sander O; Chehab G; Richter J; Bleck E; Schneider M
Lupus; 2010 Dec; 19(14):1648-53. PubMed ID: 20724351
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity.
Zizzo G; Guerrieri J; Dittman LM; Merrill JT; Cohen PL
Arthritis Res Ther; 2013; 15(6):R212. PubMed ID: 24325951
[TBL] [Abstract][Full Text] [Related]
9. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H
Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160
[TBL] [Abstract][Full Text] [Related]
10. Soluble LILRA3, a potential natural antiinflammatory protein, is increased in patients with rheumatoid arthritis and is tightly regulated by interleukin 10, tumor necrosis factor-alpha, and interferon-gamma.
An H; Chandra V; Piraino B; Borges L; Geczy C; McNeil HP; Bryant K; Tedla N
J Rheumatol; 2010 Aug; 37(8):1596-606. PubMed ID: 20595277
[TBL] [Abstract][Full Text] [Related]
11. Decreased serum thrombospondin-1 and elevation of its autoantibody are associated with multiple exacerbated clinical manifestations in systemic lupus erythematosus.
Meng Y; Zhang M; Zhao X; Cheng Y; Jia R; Wang Y; Sun X
Clin Rheumatol; 2018 Oct; 37(10):2707-2714. PubMed ID: 29998369
[TBL] [Abstract][Full Text] [Related]
12. Association of Serum T cell Immunoglobulin Domain and Mucin-3 and Interleukin-17 with Systemic Lupus Erythematosus.
Jin L; Bai R; Zhou J; Shi W; Xu L; Sheng J; Peng H; Jin Y; Yuan H
Med Sci Monit Basic Res; 2018 Oct; 24():168-176. PubMed ID: 30348938
[TBL] [Abstract][Full Text] [Related]
13. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
[TBL] [Abstract][Full Text] [Related]
14. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE. New therapeutic options?
Kanakoudi-Tsakalidou F; Farmaki E; Tzimouli V; Taparkou A; Paterakis G; Trachana M; Pratsidou-Gertsi P; Nalbanti P; Papachristou F
Lupus; 2014 Mar; 23(3):305-12. PubMed ID: 24399813
[TBL] [Abstract][Full Text] [Related]
16. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
Tripathy R; Panda AK; Das BK
Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
[TBL] [Abstract][Full Text] [Related]
18. Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.
An H; Lim C; Guillemin GJ; Vollmer-Conna U; Rawlinson W; Bryant K; Tedla N
PLoS One; 2016; 11(2):e0149200. PubMed ID: 26871720
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Serum β2-microglobulin in Egyptian Patients with Systemic Lupus Erythematosus.
Abd-Elbaky NM; Albeltagy ES; Hammour AE; Ibrahim AS
Egypt J Immunol; 2019 Jul; 26(2):143-153. PubMed ID: 31926503
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD64 on Surface of Circulating Monocytes in Systemic Lupus Erythematosus Patients: Relation to Disease Activity and Lupus Nephritis.
Abd-Elhamid YA; Eltanawy RM; Fawzy RM; Fouad NA; Atlm AM
Egypt J Immunol; 2017 Jan; 24(1):67-78. PubMed ID: 29120579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
